NCT04353180 |
|
Assessment the Activity Value of Isotretinoin 13- Cis-Retinoic Acid in the Treatment of COVID-19 Isotretinoin in Treatment of COVID-19 Randomized
|
View
|
NCT04577378 |
|
Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 An Innovative Therapeutic Approach COVID-19
|
View
|
NCT01079741 |
|
Safety Study of Adjuvant Vaccine to Treat Melanoma Patients
|
View
|
NCT04356053 |
|
Systematic Screening for Primary Immunodeficiencies in Patients Hospitalized for Severe Infections in Intensive Care
|
View
|
NCT02643303 |
|
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
|
View
|
NCT01651715 |
|
Efficacy and Safety Study of Homeopathic Oral Antibodies to Treat Viral Upper Respiratory Tract Infections
|
View
|
NCT01976585 |
|
In Situ Vaccine for Low-Grade Lymphoma Combination of Intratumoral Flt3L and Poly-ICLC With Low-Dose Radiotherapy
|
View
|
NCT02452775 |
|
Autologous OC-L Vaccine and Ovarian Cancer
|
View
|
NCT02834052 |
|
Pembrolizumab Poly-ICLC in MRP Colon Cancer
|
View
|
NCT04570332 |
|
BO-112 With Pembrolizumab in Unresectable Malignant Melanoma
|
View
|